BioSpace News Archive

Job Trends

Idled Viatris Morgantown Facility May Be Moving to West Virginia U

Viatris executive chairman Robert Coury said that seeking new stewards for the site is the best route to ensure that people will have jobs and that the property would remain useful.

August 13, 2021
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Ipsen Voluntarily Withdraws FDA Submission for FOP Drug Palovarotene

Palovarotene is being developed for the prevention of heterotropic ossification, which is new bone formation in people with fibrodysplasia ossificans progressive.

August 13, 2021
·
2 min read
·
Mark Terry
FDA

FDA Action Alert: Amgen, Seagen/Astellas, Enzon/Sesen, BioMarin and Axsome

The U.S. FDA had a very packed calendar for this week, but almost everything on it was under a Priority Review pathway.

August 13, 2021
·
6 min read
·
Mark Terry
Genetic Link to Obesity Could Expedite End to Global Epidemic

Obesity is implicated in multiple diseases that send health care costs skyrocketing. It’s not just a problem for the U.S. or Western society, either. Obesity is a global epidemic affecting adults and children alike.

August 13, 2021
·
4 min read
·
Gail Dutton
FDA

FDA OKs Pfizer-BioNTech, Moderna Boosters for Immunocompromised

The amended EUA is aimed at patients who have undergone solid organ transplants or those diagnosed with conditions that have an “equivalent level of immunocompromised.”

August 13, 2021
·
2 min read
·
Alex Keown
Drug Development

Atea’s Experimental Antiviral Shows More Promise in Preventing COVID-19

The Phase II study showed that the asset achieved antiviral activity in healthy patients and set the stage for AT-527’s potential as a preventative treatment for COVID following exposure to the virus.

August 13, 2021
·
3 min read
·
Alex Keown
Drug Development

Clinical Catch-Up: August 9-13

There was plenty of clinical trial updates last week. Here’s a look.

August 13, 2021
·
5 min read
·
Mark Terry
Drug Development

Research Roundup: Antibodies, COVID-19 and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

August 13, 2021
·
5 min read
·
Mark Terry
Drug Development

Longeveron’s Cell Therapy Shows Mixed Results in Aging Frailty

Despite the apparent flop, the company noted Lomecel-B led to a significant dose-response curve in the 6MWT compared with placebo at 180 days.

August 13, 2021
·
3 min read
·
Brandon May
Drug Development

FDA Approval of Jazz’s Xywav Will Leave More People Sleeping Less

This approval was based on the Phase III withdrawal study that showed clinically meaningful differences vs. placebo in change to the primary endpoint, Epworth Sleepiness Scale score.

August 13, 2021
·
2 min read
·
Mark Terry